StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3081% below fair value
$6.10−0.51 (-7.72%)

Close on Nov 18, 2026Market cap $24.59MP/E –Yield –

Rockwell Medical revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Rockwell Medical's revenue for the twelve months ending Jun 30, 2026 was $69.39M, down 21.1% year over year. For fiscal 2025 it was $69.26M, down 31.8% from the year before. Over ten years it grew 2.3% a year on average. The highest annual figure on record is $101.49M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$69.26M-31.8%
FY2024Dec 31, 2024$101.49M+21.4%
FY2023Dec 31, 2023$83.61M+14.8%
FY2022Dec 31, 2022$72.81M+17.6%
FY2021Dec 31, 2021$61.93M-0.4%
FY2020Dec 31, 2020$62.20M+1.5%
FY2019Dec 31, 2019$61.30M-3.3%
FY2018Dec 31, 2018$63.39M+10.6%
FY2017Dec 31, 2017$57.30M+7.5%
FY2016Dec 31, 2016$53.28M-3.7%
FY2015Dec 31, 2015$55.35M+2.1%
FY2014Dec 31, 2014$54.19M+3.5%
FY2013Dec 31, 2013$52.38M+5.1%
FY2012Dec 31, 2012$49.84M+1.8%
FY2011Dec 31, 2011$48.97M-17.8%
FY2010Dec 31, 2010$59.55M+8.8%
FY2009Dec 31, 2009$54.73M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$17.78M+10.6%
Q1 FY2026Mar 31, 2026$17.34M-8.3%
Q4 FY2025Dec 31, 2025$18.35M-25.6%
Q3 FY2025Sep 30, 2025$15.93M-43.8%
Q2 FY2025Jun 30, 2025$16.07M-37.8%
Q1 FY2025Mar 31, 2025$18.91M-16.6%
Q4 FY2024Dec 31, 2024$24.67M+11.6%
Q3 FY2024Sep 30, 2024$28.32M+19.1%
Q2 FY2024Jun 30, 2024$25.83M+42.9%
Q1 FY2024Mar 31, 2024$22.68M+15.3%
Q4 FY2023Dec 31, 2023$22.09M+14.4%
Q3 FY2023Sep 30, 2023$23.77M+27.2%
Q2 FY2023Jun 30, 2023$18.08M-3.2%
Q1 FY2023Mar 31, 2023$19.67M+22.0%
Q4 FY2022Dec 31, 2022$19.31M+26.0%
Q3 FY2022Sep 30, 2022$18.69M+16.9%
Q2 FY2022Jun 30, 2022$18.68M+23.4%
Q1 FY2022Mar 31, 2022$16.12M+4.2%
Q4 FY2021Dec 31, 2021$15.33M+1.1%
Q3 FY2021Sep 30, 2021$15.99M+4.6%
Q2 FY2021Jun 30, 2021$15.14M-4.8%
Q1 FY2021Mar 31, 2021$15.47M-2.4%
Q4 FY2020Dec 31, 2020$15.16M-2.1%
Q3 FY2020Sep 30, 2020$15.28M-0.8%
Q2 FY2020Jun 30, 2020$15.90M+7.1%
Q1 FY2020Mar 31, 2020$15.86M+1.9%
Q4 FY2019Dec 31, 2019$15.49M-8.1%
Q3 FY2019Sep 30, 2019$15.41M-7.6%
Q2 FY2019Jun 30, 2019$14.85M-0.5%
Q1 FY2019Mar 31, 2019$15.56M+4.1%
Q4 FY2018Dec 31, 2018$16.85M+13.6%
Q3 FY2018Sep 30, 2018$16.67M+14.0%
Q2 FY2018Jun 30, 2018$14.91M+12.6%
Q1 FY2018Mar 31, 2018$14.95M+2.4%
Q4 FY2017Dec 31, 2017$14.84M+10.8%
Q3 FY2017Sep 30, 2017$14.63M+14.1%
Q2 FY2017Jun 30, 2017$13.24M–
Q1 FY2017Mar 31, 2017$14.59M–
Q4 FY2016Dec 31, 2016$13.39M–
Q3 FY2016Sep 30, 2016$12.81M–

More Rockwell Medical figures

See a number that looks wrong?